Fraunhofer IBMT in Saarland attractive for South Korean biotech scene
High-ranking international industry visiting the Fraunhofer Institute for Biomedical Engineering - IBMT and ROKIT conclude cooperation in the field of medical biotechnology.
Press release / 6.7.2017
A Memorandum of Understanding (MoU) lays the foundation for future collaboration between the Fraunhofer IBMT, Sulzbach, and the well-known South Korean company ROKIT. As part of a symposium in the field of medical biotechnology at the Fraunhofer IBMT, both partners signed a letter of intent on 5 July 2017 to work together in the future fields of regenerative medicine and organ pressure.
The international competence of the Fraunhofer Institute for Biomedical Engineering IBMT in the fields of stem cell research, automated in-vitro culture equipment and tissue engineering paired with the many years of intensive contacts of the IBMT to South Korea forms the starting point of a visit to the South Korea's well-known launch site. ups ROKIT at the Fraunhofer IBMT. The Fraunhofer IBMT has been successfully working in the field of stem cell research for many years. For the pharmaceutical industry, these cells represent the ultimate test system; human induced pluripotent stem cells (hiPS) are used to personalize therapies. The generation / generation, expansion and cryopreservation of hiPS cells is currently very time-consuming and labor-intensive. To remedy this situation, the Fraunhofer IBMT, together with international partners from science and industry, is building a cell bank of more than 50 human iPS cell lines in the major European project »EBiSC - European Bank for induced pluripotent Stem Cells also academic centers should be used.
The 5-year-old emerging South Korean company ROKIT, headquartered in Seoul, has made a name for itself worldwide in the 3D printer market. A so-called »fourth dimension« will in future be achieved by a new, flexible bio 3D printer »ROKIT IN VIVO«, which generates cellular structures. From the cultured framework - in the future also with differentiated hiPS cells - a functional tissue emerges, which can be used for tissue engineering and regenerative medicine.
This represents just one element in the large intersection with the fields of activity of the Fraunhofer IBMT, based in Sulzbach, which has been active in the international growth market of life sciences and medicine / (bio) medical technology for 25 years and is primarily a technology developer and device manufacturer for customers from all over the world understands.
Dr. Heon Ju Lee, Managing Director of ROKIT, Seok Hwan You, CEO & Founder ROKIT, and Ms. Ji Hye Shin, Manager Overseas Business Development Division ROKIT, visited the Fraunhofer IBMT in Sulzbach on July 5, 2017 to discuss cooperation opportunities in a symposium To concretize the growth market of medical biotechnology, especially regenerative medicine and tissue / organ pressure. By signing the MoU, both partners reaffirm their intention to intensify future cooperation. The visit of the Korean guests was accompanied by the state-owned Saarland Economic Development Corporation.
»We are pleased that the charisma of our institute in the Saarland beyond the European borders has drawn the worldwide rising and well-known company ROKIT to our attention. With the aim of identifying common fields of action, we are now starting the exchange for a trusting and successful cooperation, "says Prof. Dr. med. Heiko Zimmermann, Director of the Fraunhofer IBMT.